Glenmark Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts

Glenmark Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter

Conference/Earnings Calls Alerts

Search Inside the pdf :

Glenmark Pharmaceuticals Ltd.

04 Feb 2026

2136.70

0.58%

Earnings Call

Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

The transcript of the Earnings Call held on Monday, February 02, 2026 has been uploaded on the Company''s website.

Glenmark Pharmaceuticals Ltd.

02 Feb 2026

2136.70

0.58%

Glenmark Pharmaceuticals Results Earnings Call for Q3FY26

Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q3FY26 Performance and Outlook. Listen to the full earnings transcript.

Glenmark Pharmaceuticals Ltd.

19 Nov 2025

2136.70

0.58%

Earnings Call

Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Earnings Call is attached

Glenmark Pharmaceuticals Ltd.

17 Nov 2025

2136.70

0.58%

Glenmark Pharmaceuticals Results Earnings Call for Q2FY26

Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q2FY26 Performance and Outlook. Listen to the full earnings transcript.

Glenmark Pharmaceuticals Ltd.

18 Aug 2025

2136.70

0.58%

Glenmark Pharmaceuticals Results Earnings Call for Q1FY26

Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q1FY26 Performance and Outlook. Listen to the full earnings transcript.

Glenmark Pharmaceuticals Ltd.

23 Jul 2025

2136.70

0.58%

Earnings Call

Glenmark Pharmaceuticals Ltd - 532296 - Audio Recording Of The Glenmark Pharmaceuticals Limited - Investor Day …

BSE India

Audio recording of Investor Day 2025 held on 16th July, 2025.

Glenmark Pharmaceuticals Ltd.

27 May 2025

2136.70

0.58%

Earnings Call

Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Further to our letter dated 19th May, 2025 and pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (LODR), Regulations 2015, the transcript of the Earnings call held on Monday, May 26, 2025 for the fourth quarter ended March 31, 2025 has been uploaded on the Company''s website.

Glenmark Pharmaceuticals Ltd.

26 May 2025

2136.70

0.58%

Earnings Call

Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of Q4 FY 2024-25 earnings call held on 26th May, 2025 on the website of the Company.

Glenmark Pharmaceuticals Ltd.

26 May 2025

2136.70

0.58%

Glenmark Pharmaceuticals Results Earnings Call for Q4FY25 & Full Year

Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

Glenmark Pharmaceuticals Ltd.

19 Feb 2025

2136.70

0.58%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Further to our letter dated 5th February, 2025 and pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (LODR), Regulations 2015, the transcript of the Earnings Call held on Monday, 17th February, 2025 for the third quarter ended December 31, 2024 has been uploaded on the Company''s website.